WATCHLONGEVITY

Monday, May 4, 2026

NOTABLE68
SAFETYLimited grounding

Eli Lilly's GLP-1 lawsuit against Houston's Empower Pharmacy partially dismissed - Houston Chronicle

A court partially dismissed Eli Lilly's lawsuit against Empower Pharmacy, a Houston compounding pharmacy that makes GLP-1 drugs (weight-loss and diabetes medications). The case involves a dispute over whether pharmacies can legally make cheaper copies of these drugs.

Analysis

Partial dismissal of Lilly's suit against Empower weakens the brand-side legal playbook against GLP-1 compounders, prolonging cheaper copy availability.

  • Court partially dismissed Eli Lilly's lawsuit against Empower Pharmacy
  • Empower is a Houston compounding pharmacy producing GLP-1 drugs
  • Case centers on legality of compounded copies of GLP-1 medications
$LLY
glp-1Eli LillyEmpower Pharmacy
Compounding GLP-1 News3d
Read
Court dismisses part of Lilly lawsuit against Empower, some claims can proceed
NOTABLE68
SAFETYLimited grounding

Court dismisses part of Lilly lawsuit against Empower, some claims can proceed

A judge dismissed some of Eli Lilly's lawsuit against Empower Pharmacy, which was accused of misleading customers about its homemade copies of tirzepatide (a weight-loss drug). The court allowed some of Lilly's claims to move forward.

Analysis

Mixed ruling keeps Lilly's pressure campaign on compounders alive but narrows it, signaling courts will scrutinize tirzepatide copy claims case-by-case rather than wholesale.

  • Court dismissed part of Lilly's lawsuit against Empower Pharmacy
  • Some Lilly claims against Empower allowed to proceed
  • Suit concerns Empower's compounded copies of tirzepatide
$LLY
tirzepatideEli LillyEmpower Pharmacy
Endpoints News3d
Read
NOTABLE62
SAFETYLimited grounding

Judge dismisses part of Eli Lilly's GLP-1 lawsuit against Houston's Empower Pharmacy - MSN

A judge threw out part of Eli Lilly's lawsuit against Empower Pharmacy, a Houston company that makes GLP-1 drugs (weight-loss and diabetes medicines) without a brand name. The decision limits how much of Eli Lilly's case can move forward in court.

Analysis

Partial dismissal of Lilly's suit against Empower is a marginal win for compounders defending GLP-1 production, though the core case continues.

  • Judge dismissed part of Eli Lilly's GLP-1 lawsuit against Empower Pharmacy
  • Empower is a Houston-based compounder of GLP-1 drugs
  • Ruling limits scope of Lilly's case going forward
$LLY
glp-1Eli LillyEmpower Pharmacy
Compounding GLP-1 News21h
Read